Tg Therapeutics Inc (TGTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TGTX? Forum Prognose Aktiensplit

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.09% 192.57	161.71	141.15	120.86	108.19
Cost Of Revenue	35.77% 38.14	28.09	18.94	15.54	15.40
Gross Profit	15.58% 154.43	133.62	122.21	105.31	92.79
Operating Expenses	0.30% 103.94	104.25	87.37	96.69	62.84
Benefits Costs and Expenses	8.60% 147.48	135.80	110.23	115.39	82.73
Costs And Expenses	7.36% 142.08	132.34	106.31	112.23	78.24
Operating Income/Loss	71.95% 50.49	29.36	34.84	8.622	29.95
Nonoperating Income/Loss	56.28% -5.401	-3.456	-3.923	-3.154	-4.496
Income/Loss From Continuing Operations Before Tax	74.04% 45.09	25.91	30.92	5.468	25.45
Income Tax Expense/Benefit, Deferred	18.63	-	-	-	-
Income Tax Expense/Benefit	106.04% 22.06	-364.99	2.733	0.408	2.122
Income/Loss From Continuing Operations After Tax	94.11% 23.04	390.89	28.19	5.06	23.33
Net Income/Loss	94.11% 23.04	390.89	28.19	5.06	23.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	101.35% -1.9568	145.42	146.74	146.68	-0.0249
Diluted Average Shares	100.43% -0.6896	161.00	162.56	162.77	-0.0309
Basic Earnings Per Share	92.57% 0.20	2.69	0.19	0.03	0.16
Diluted Earnings Per Share	93.83% 0.15	2.43	0.17	0.03	0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%